View
224
Download
0
Embed Size (px)
Citation preview
8/10/2019 Wound Assess 01.10.10
1/115
,Documentation &
Management
HHC Health & Home Care
. , ,
8/10/2019 Wound Assess 01.10.10
2/115
ec ves
List six elements to include when assessing anddocumenting wounds
escr e e our ssue ypes oun n e wounbed
Differentiate pressure ulcer stages as defined byNPUAP
Define surgical wound and stasis ulcer using theOASIS definition
Identify wound classification/etiology
List appropriate wound management that provide
8/10/2019 Wound Assess 01.10.10
3/115
n ro uc on
Success Drives the care plan in motion
esponse o ems
Impact on reimbursement
Determines necessary resource utilization Quality Indicators depend on accurate/consistent
assessment Emergent Care for Wound Infection, Deteriorating Wound
Increase in Number of Pressure Ulcer
Improvement in Number of Surgical Wounds
8/10/2019 Wound Assess 01.10.10
4/115
n ro uc oncon
Interventions
To discharge patient with patient or caregiver
To keep free of infection
To revent rehos italization
To prevent skin breakdown
8/10/2019 Wound Assess 01.10.10
5/115
Two Primary Layers of the
n
< 1mm thickness, avascular
Regenerates on average every 28-30 days
Melanocytes produce and distribute melanin, the
brown pigment of skin
environmental antigens
Dermis innermost layer supports & nourishes epidermis
Collagen, fibroblast
Extra cellular matrix formation
8/10/2019 Wound Assess 01.10.10
6/115
Anatom : Human Skin
8/10/2019 Wound Assess 01.10.10
7/115
n ruc ure
8/10/2019 Wound Assess 01.10.10
8/115
a or unc ons o e n
,
Thermoregulation & Excretion regulates
Sensation pain, touch, temperature andressure
Metabolism vitamin D synthesis inpresence of sunlight
Communication body image
8/10/2019 Wound Assess 01.10.10
9/115
n s e ge
8/10/2019 Wound Assess 01.10.10
10/115
Skin as We Age
Easily traumatized Decrease in sebaceous lands
Decrease in immune response
Chan es in thermore ulation
Less elasticity
8/10/2019 Wound Assess 01.10.10
11/115
ypes o oun ea ng
. -
Edges approximated
owers r s o n ect on
Involves little tissue loss/defectHeals with minimal scarring
8/10/2019 Wound Assess 01.10.10
12/115
ypes o oun ea ng
.
Chronic wounds e.g.: Pressure ulcers,
allowed to heal by production of scar
tissuea. Edges not approximated
b. Greater tissue loss
c. Higher risk of infection
d. Longer healing times
8/10/2019 Wound Assess 01.10.10
13/115
ypes o oun ea ng
3. er ary e aye r mary n en on
(delay between injury and closure)
Surgical wounds left open for 3-5 days
Closed with sutures, staples or adhesive skin
Heals with more scar tissue than primary
8/10/2019 Wound Assess 01.10.10
14/115
Three Phases of WoundHealing
Inflammatory Phase reactive phase 4-6 days of cellular infiltration
Phagocytosis neutrophil remove
necrotic tissue, macrophage ingestac er a, ac va e o re ease grow
factors
factors, blood vessels dilate
8/10/2019 Wound Assess 01.10.10
15/115
8/10/2019 Wound Assess 01.10.10
16/115
Three Phases of Healingcont
4 - 24 days for normal non-infected wounds Fills the wound with connective tissue
granu a on
Contracts the wound edges (contraction)
Covers the wound with epithelium
Fibroblasts cellular proliferation, synthesizecollagen, release growth factors
An io enesis formation of new blood vessels
Granulation major tissue fills wound bed(connective)
8/10/2019 Wound Assess 01.10.10
17/115
Proliferative Phase
phase last several weeks
buds or granule tissues ranu a on o ssue, ro as
stimulate the production of collagen
Margins pull together, decreasing thewound size
8/10/2019 Wound Assess 01.10.10
18/115
Proliferative Phase
8/10/2019 Wound Assess 01.10.10
19/115
Proliferative Phase Contraction
8/10/2019 Wound Assess 01.10.10
20/115
Proliferative Phase
- ,
light purple from edges in full thickness wounds
8/10/2019 Wound Assess 01.10.10
21/115
ree ases o ea ngcont
Remodeling collagen fibers rearrange,
Increase tensile strength
8/10/2019 Wound Assess 01.10.10
22/115
Maturation Phase
emo e ng p ase
lasts 21 days to months
Process continues until
regained about 80% of
strength
8/10/2019 Wound Assess 01.10.10
23/115
oun ea ng asca e
-
MaturationProliferative/
Fibroblastic
Remodeling
Granulation
8/10/2019 Wound Assess 01.10.10
24/115
Wound Assessment, Documentation
& Management
Head to Toe SkinAssessment
Risk Assessment Identify Causative Factors,
- a en s ory
Type/Classification of
Wound
Nutritional and Hydration
Status
Wound Etiology
Location
Vascular Status
Environmental and
Appearance, Shape
Pain
8/10/2019 Wound Assess 01.10.10
25/115
Whats wrong with this patient?
8/10/2019 Wound Assess 01.10.10
26/115
Wound Location The wound location
should be precisely
identified
such as left or right,
medial or distal, and
location
Buttocks: sacral
coccyx, ischium,trochanteric, etc.
, ,Suprapubic, etc.
8/10/2019 Wound Assess 01.10.10
27/115
Width side to side; greatest width
Depth from visible to the deepest area
8/10/2019 Wound Assess 01.10.10
28/115
oun mens ons
,
sterile cotton tipped applicator into thedee est art of the wound bed ras the
applicator at skin level, and then measure the
applicator from its tip to your fingers
8/10/2019 Wound Assess 01.10.10
29/115
Wound Base
Granulation red/pink and beefy appearance
Epithelial bridging
u
Slough yellow, tan
sc ar ac , rown
8/10/2019 Wound Assess 01.10.10
30/115
ranu a on p e a za on
,
berry like red or pink
Epithelial tissue dry,deep pink to pearly
ink li ht ur le fromedges in full thicknesswounds or may form
wounds
8/10/2019 Wound Assess 01.10.10
31/115
usc e, en on an one
Muscle pink to dark
red, firm, highly
muscles shiny white,
thin to thick, contains
muscle or muscle group
Bone
8/10/2019 Wound Assess 01.10.10
32/115
Eschar and Slou h
8/10/2019 Wound Assess 01.10.10
33/115
a s unne ng
extend in any direction from the wound and
abscess formation
8/10/2019 Wound Assess 01.10.10
34/115
What is Underminin ?
intact skin along the wound margins
Space between the surrounding skin andthe wound bed
wound edge
May extend entirely around wound
Subcutaneous fat necrosis Usually indicates aerobic and anaerobic
8/10/2019 Wound Assess 01.10.10
35/115
How to Measure Tunneling
n erm n ng
-
applicator gently to
centimeters
Describe the locationusing the face of a
clock, with 12 oclock
at the patients headand 6 oclock at the
8/10/2019 Wound Assess 01.10.10
36/115
Wound Sha e & Ed es
Round
Crater-like
- Intact (or not)
Callous
Macerated Desiccated
8/10/2019 Wound Assess 01.10.10
37/115
oun gescon
Fibrotic / firm
epibole
8/10/2019 Wound Assess 01.10.10
38/115
Periwound Skin
Edema Pitting
on p tt ng
Induration
Er thema Periwound Pain
Maceration
asAbsence of hair
8/10/2019 Wound Assess 01.10.10
39/115
er woun ncon
, ,
Presence of foreign bodies sutures, drain, , ,
metal, dirt, bone/metal)
Er thema redness irritation dermatitisdemarcated borders, red streaking. In darkskin, may appear purple or a gray hue or
eepen ng o e e n c s n co or Dry skin
8/10/2019 Wound Assess 01.10.10
40/115
oun xu a eWOUND ODORWOUND ODOR WOUND DRAINAGEWOUND DRAINAGE
Clean or irrigate woundwith NS
Describe exudate: Amount
o e e presence orabsence of odor
o or
Types
Serous clear to straw Serosanguinous slightly
bloody
Sanguineous - bloody
Fibrinous composed offibrin and cells
Purulent thicker,opaque and colorful
8/10/2019 Wound Assess 01.10.10
41/115
Wound Exudate haracteristicsExudate Type Color Consistency Significance
Sanguineous/ Red Thin, watery Indicates low blood vessel
Bloody grow or srup on o
blood vesselsSero-sanguineous Light Thin, watery Normal during
red to
pink
inflammatory and
proliferative phases of
healing.Serous Clear,
light
color
Thin, watery Normal duringinflammatory and
proliferative phases of
healing.Seropurulent Cloudy,
yellowThin, watery May be first signal of
impeding wound infection
to tan
Purulent/pus Yellow,tan or
Thick, opaque Signals wound infection;ma be associated with
8/10/2019 Wound Assess 01.10.10
42/115
easur ng a n
wound or periwound area
s e pa en o ra e e pa n on a sca e o
0-10, with 0 indicating no pain and 10 severe
7 to 10 is mitigating pain
8/10/2019 Wound Assess 01.10.10
43/115
Classification of Wounds b :
ACUTECHRONIC
sua y rauma orsurgery
Heals quickly through awell orchestrated process
Healing not timely ororderly
3 phases of healing withlimited local care
onger ea ng me ueto
Pressurehours)
Inflammatory (0 to 3
Inflammation
Poor nutrition
ays
Proliferative (3-21days)
Poor circulation
Ma re uire active wound Maturation (21 days-
1.5 years)
treatment to heal
8/10/2019 Wound Assess 01.10.10
44/115
Pressure Neuropathic - diabetic
Venous insufficiency
Arterial
Dehisced Surgical Wound
Others: Malignancy,
Vasculitis, Fistula,Pyoderma Gangraenosum
8/10/2019 Wound Assess 01.10.10
45/115
oun ass ca on y ep
- -
epidermis and possiblepartial loss of dermis
-
destruction extendingthrough the dermis to
Shallow wounds
No granulation tissue
involve the subcutaneous
layer and possibly muscle
erma repa r w
epithelial tissue
tissue
Wound contraction
partial-thickness Epithelialization
8/10/2019 Wound Assess 01.10.10
46/115
urg ca oun omp ca ons
-
Wound Dehiscence acute wound failure,woun srup on, a om na woun
separation
ccurs y e an ay pos opera ve
About half are associated with infection
, ,
Hypoproteinemia, Hypertension, DM
8/10/2019 Wound Assess 01.10.10
47/115
urs ng ssessmen
Assess incision site for any signs and symptoms ofinfection
Heat Elevated WBC
Purulence ncrease ra nage assess ress ng or s gns o ooz ng
Odor
Changes in wound appearance and surrounding tissue
easure woun nc s on
Wound Care Sheet use to document progress andnon progress of wound status
8/10/2019 Wound Assess 01.10.10
48/115
M1340 Does this patient have
a Surgical Wound?
Yes, patient has at
surgical wound
Surgical wound knownbut not observable due
to non-removable
Cast or dressing per
physician order
8/10/2019 Wound Assess 01.10.10
49/115
What is a Surgical Wounds &
What is Not?
Central line sites Sta led or sutured
Surgery to the mucosalmembranes,
incisions
Wound with drains
Gynecological surgicalprocedure via vaginal
Medi-port sites
Implanted infusion
PICC line
access devices I & D with excision
Debridement orplacement of skin graft
8/10/2019 Wound Assess 01.10.10
50/115
(Observable) Surgical Wound
Most problematic largest, most resistant totreatment, or an infected surgical wound
Identifies the degree of healing Newly epithelialized incision well approximated, complete
e ithelialization Fully granulating no s/s of infection, no dead space, no
avascular tissue
,
edges open Not healing - >25% avascular tissue, closed edges,
,
8/10/2019 Wound Assess 01.10.10
51/115
an an n erven ons
surgery
surgery
Pain relief as needed Provide information to patient/caregiver related to
wound healing process and signs and symptoms of
woun comp ca ons n ec on
Provide emotional support related to reason for
8/10/2019 Wound Assess 01.10.10
52/115
urg ca oun n a s
Surgical Wound Post Removal of
8/10/2019 Wound Assess 01.10.10
53/115
Surgical Wound Post Removal of
e en on u ures onTherapy
Surgical Wound 3 weeks VAC
8/10/2019 Wound Assess 01.10.10
54/115
Surgical Wound 3 weeks VAC
erapy
S i l W d 4 k t
8/10/2019 Wound Assess 01.10.10
55/115
Sur ical Wound 4 weeks ost
VAC
8/10/2019 Wound Assess 01.10.10
56/115
ressure cers
Compression mechanical injury o ssue compresse e ween wo ar
surfaces
impaired, decreasing the supply of oxygen and
Injury External Factors:Pressure
ShearFriction
Maceration
Pressure Points
8/10/2019 Wound Assess 01.10.10
57/115
Pressure PointsSUPINE POSITION SITTING POSITION
Occiput Scapula Sacrum Heels
. . . .
LATERAL PRESSURE
Ischium 8%
ElbowTrochanter Knee
6%
Malleolus 6.1%
..
Piper B. Mechanical Forces: Pressure, Shear, and Friction. In Bryant & Nix (Eds.)Acute and Chronic Wounds:
Current management concepts (3rd Ed.) Mosby. 2007
Braden Scale For Predicting Press re
8/10/2019 Wound Assess 01.10.10
58/115
Braden Scale For Predicting PressureUlcer Risk
, ,
activity, mobility, nutrition, friction & shear
Four Severity: 1. completely limited, 2. very limited,
3. slightly limited, 4. no impairment
The intensity and duration of pressure
Sensory perception, mobility, activity Tissue intolerance for pressure
Moisture, nutrition, friction/shear
8/10/2019 Wound Assess 01.10.10
59/115
8/10/2019 Wound Assess 01.10.10
60/115
rogress on o ressure cer
8/10/2019 Wound Assess 01.10.10
61/115
this patient assessed for Risk of
0 - No assessment conducted [ Go to M1306 ]
1 - Yes, based on an evaluation of clinical factors,
e.g., mobility, incontinence, nutrition, etc., without
2 - Yes, using a standardized tool, e.g., Braden,
Norton, other
Alwaysanswer #2
8/10/2019 Wound Assess 01.10.10
62/115
M1302
(M1302) Does this patient have a Risk of
Developing Pressure Ulcers?
0 - No
1 - Yes
Remember!
A score of 18 & below
requires intervention
to prevent pressure
ulcers
62
If Patient High Risk, Did Intervene
8/10/2019 Wound Assess 01.10.10
63/115
g ,
mp emen Restorative Nursin
Incontinence Management (skin care, moisture barrier, absorbent
pads or diapers, offer bedpan/urinal, increase water intake) Bladder/Bowel Training
Pressure Ulcer Prevention/Management Turning & Positioning, Prevent Friction and Shear
Pressure Reduction Support Surface
Improve Mobility
Transfer/Positioning
Moist Wound Healing Wound Bed Preparation
Nutrition
M1306 - Does this patient have at least one
8/10/2019 Wound Assess 01.10.10
64/115
designated as unstageable ?
Depth must be visible to accurately stage
Answer No or (Go to M1322)
, , ,
Select NO if
Stage 2 pressure ulcer has healed and
There are no other pressure ulcers
Remember! Stage 3 and 4 can never be considered fully healed.They may be closed, the wound surface is covered with new
.
8/10/2019 Wound Assess 01.10.10
65/115
- -
Pressure Ulcerthat is present at discharge
-
2 - Developed since the most recent SOC/ROC assessment:record date pressure ulcer first identified:
_ __ /__ __ /__ __ __ __
month / day / year
NA - No non-e ithelialized Sta e II ressure ulcers are resent atdischarge
65
8/10/2019 Wound Assess 01.10.10
66/115
age ressure cer
dermis presenting as a
shallow open ulcer with a
Without slough
An intact or open/rupturedserum- filled blister
Can only heal by the
epithelialization
process of regenerationof the epidermis across
M1308 Current Number of Unhealed (non-
8/10/2019 Wound Assess 01.10.10
67/115
(
ep e a ze ressure cer a ac age(Enter 0 if none; excludes Stage 1 pressure ulcers)
Column 1
Completed at
SOC/ROC/FU & D/C
Stage Description- Unhealed pressure ulcer Number CurrentlyPresent
a. Stage II----
b. Stage III----
c. Stage IV----
d. 1 Unstageable: Known or l ikely but
unstageable due to non-removable dressing or
----
device
d. 2 Unstageable: Due to coverage of wound ----
d. 3 Unstageable: Suspected deep t issue
injury in evolution----
8/10/2019 Wound Assess 01.10.10
68/115
age ressure cer
loss
be visible but bone,
tendon or muscle are
not exposed
Slough may be present
ay nc u e unne ng
and undermining
8/10/2019 Wound Assess 01.10.10
69/115
age ressure cer
loss with exposedbone, tendon, or
muscle
Slough or eschar may
be present on some
parts of the wound bed
undermining andtunneling
8/10/2019 Wound Assess 01.10.10
70/115
ns agea e ressure cer
loss in which the baseof the ulcer is covered
by slough (yellow, tan
gray, green, or brown)
,brown, or black) in the
wound bed
8/10/2019 Wound Assess 01.10.10
71/115
uspec e eep ssue n ury
bruising
Blood-filled blister dueto damage ofunderlying soft tissue
from ressure and/orshear
Painful, firm, mushy,,
cooler as compared toadjacent tissue
Suspected Deep Tissue Injury
8/10/2019 Wound Assess 01.10.10
72/115
Evolution Pressure related
injury to
subcutaneous tissueunder intact skin
,have the appearanceof a deep bruise
quickly
May lead todevelopment of
age or
pressure ulcer, evenunder optimaltreatment
Black J. Adv.in Skin & Wound Care 2005;18(8):415-421
M1308 at Recertification and
8/10/2019 Wound Assess 01.10.10
73/115
sc arge
Step Two If there is a wound in column1
If present at SOC or ROC include that wound in
column 2 If after SOC or ROC do not include in column 2
Step Three If there is a 0 in column 1 then
make sure there is a 0 in column 2
M1308 Current Number of Unhealed (non-
8/10/2019 Wound Assess 01.10.10
74/115
ep e a ze ressure cer a ac age(Enter 0 if none; excludes Stage 1 pressure ulcers)Column 1 Column 2
omp e e a
SOC/ROC/FU & D/C
omp e e a
Stage Description- Unhealed pressure ulcer Number Currently Present Number of those listed in
Column 1 that were present
on admission (most recent
SOC/ROC)
a. Stage II0 0
b. Stage III0 0
c. Stage IV1 1
d. 1 Unstageable: Known or likely but
unstageable due to non-removabledressing or device 0 0d. 2 Unstageable: Due to coverage of
wound bed by s lough and/or eschar
d. 3 Unstageable: Suspected deep tissue
injury in evolution 1 0
Directions for M1310, M1312 and M1314
8/10/2019 Wound Assess 01.10.10
75/115
If the patient has one or more unhealed (non-epithelialized)
Stage III or IV pressure ulcers, identify the Stage III or IV
width) and record in centimeters. If no Stage III or Stage IV
pressure ulcers, go to M1320
75
Length Head to Toe Width Side to Side
-
8/10/2019 Wound Assess 01.10.10
76/115
(Observable) Pressure Ulcer:
0 Newly epithelialized
1 Fully granulating
3 Early/partial granulation
4 Not healing
NA No observable ulcer
Identifies the degree of closure visible in themost problematic observable pressure ulcer,s age or g er
8/10/2019 Wound Assess 01.10.10
77/115
Pressure Ulcer Post Surgical
8/10/2019 Wound Assess 01.10.10
78/115
e r emen
Pressure Ulcer Post
8/10/2019 Wound Assess 01.10.10
79/115
y roge ress ng x a ee
M1322 Current Number of
8/10/2019 Wound Assess 01.10.10
80/115
age ressure cers
blanchable rednessover a bony
,2 pressure ulcer statusof healing is non-
prom nences
Difficult to detect in
individuals with dark
ea ng
skin tones
May not have visible
differ from surroundingarea
8/10/2019 Wound Assess 01.10.10
81/115
cenar o s. . .
Negron still has one stage 2 PU that was presentat SOC. A fully epithelialized stage 3 at SOC isnow a s age . nswer urrenNumber of Unhealed Pressure Ulcers.
2. How would you complete M1308 Current Numberof Unhealed Pressure Ulcers if Mrs. Negron now
implications does this have for our patient? Ouragency quality measure?
M1308 Current Number of Unhealed (non-
8/10/2019 Wound Assess 01.10.10
82/115
ep e a ze ressure cer a ac age(Enter 0 if none; excludes Stage 1 pressure ulcers)Column 1 Column 2
omp e e a
SOC/ROC/FU & D/C
omp e e a
Stage Description- Unhealed pressure ulcer Number Currently Present Number of those listed inColumn 1 that were present
on admission (most recent
SOC/ROC)
a. Stage II1 1
b. Stage III0 0
c. Stage IV1 1
d. 1 Unstageable: Known or likely but
unstageable due to non-removabledressing or device 0 0
.
wound bed by s lough and/or eschar
d. 3 Unstageable: Suspected deep tissue
injury in evolution 0 0
M1308 Current Number of Unhealed (non-
8/10/2019 Wound Assess 01.10.10
83/115
ep e a ze ressure cer a ac age(Enter 0 if none; excludes Stage 1 pressure ulcers)Column 1 Column 2
omp e e a
SOC/ROC/FU & D/C
omp e e a
Stage Description- Unhealed pressure ulcer Number Currently Present Number of those listed inColumn 1 that were present
on admission (most recent
SOC/ROC)
a. Stage II1 1
b. Stage III0 0
c. Stage IV1 1
d. 1 Unstageable: Known or likely but
unstageable due to non-removabledressing or device 0 0d. 2 Unstageable: Due to coverage of
wound bed by s lough and/or eschar
d. 3 Unstageable: Suspected deep tissue
injury in evolution 1 0
8/10/2019 Wound Assess 01.10.10
84/115
M1300 SOC/ROC Was the patient assessed for
Risk of Developing Pressure Ulcer? oes e p ys c an or ere
plan of care including interventions to prevent
M2400 Transfer/Discharge Were the following
-
ordered POC and implemented?
8/10/2019 Wound Assess 01.10.10
85/115
rocesses easure n
Care Plan
me y are
Assessment
mp emen a on
Education
Prevention
Care Planning
Care Coordination
8/10/2019 Wound Assess 01.10.10
86/115
ommun ca on
Report of Assessment Findings Parameters
Change in Condition/Status
Lab work test results
-outcomes during past 60 days
Verbal Orders Change of treatment, medications, additional discipline
including visit frequency, duration and interventions
8/10/2019 Wound Assess 01.10.10
87/115
ressure cer anagemen ,
friction and shear Support surface
Lift sheet, overhead trapeze
Turning and positioning, maximize mobility
Incontinent care, bladder/bowel training
Moisture barrier
u r on ro e n, ncrease ca or e, supp emen
with multivitamin (Vit A, C & E), zinc
8/10/2019 Wound Assess 01.10.10
88/115
oun anagemen r nc p es
Pressure, Shear, Friction Moisture
Circulator Im airment
Neuropathy
Provide Systemic Support to Reduce Existing
and Potential Cofactors
Nutritional and Fluid Support
Control of Systemic Condition Affecting Wound Healing i.e., blood glucose
Wound Management
t
8/10/2019 Wound Assess 01.10.10
89/115
r nc p escont.
Prevent and Manage Infection
Remove Nonviable Tissue (debridement)
Eliminate dead space
Eliminate or Minimize Pain
TIME Princi les of Wound Bed
P ti
8/10/2019 Wound Assess 01.10.10
90/115
Preparation
T Tissue nonviable or deficient
I Infection or inflammation
M Moisture imbalance
w u - v
Treatment Options: Moist
W d E i t
8/10/2019 Wound Assess 01.10.10
91/115
Wound Environment
loosely Debridement,
HydrocolloidHyperbaric, Topical
Antimicrobial Agents,
Foam ,
Dermal Graft
Negative Pressure Wound Therapy
Management of Lower
E t it Ul
8/10/2019 Wound Assess 01.10.10
92/115
Extremity Ulcers
Venous Insufficiency 85% of lower limb ulcer
Arterial Insufficiency
Diabetic/Neuropathy
Vascular Anatomy of the
ower x rem y
8/10/2019 Wound Assess 01.10.10
93/115
ower x rem y
rich blood to the foot, then return the O2de leted blood back to the heart Superficial veins
Deep veins
Communicating veins
Arterial and/or venous system canma unc on
Recognizing and evaluating pathology
enous as s cers
8/10/2019 Wound Assess 01.10.10
94/115
enous as s cers
veins leads to venous
hypertension venous blood does not
completely leave theveins
Fluids leaks from thevessels and formsedema in the tissue
we ng
Development of ulcers inankle or calf
Signs and Symptoms of
enous nsu c ency
8/10/2019 Wound Assess 01.10.10
95/115
enous nsu c ency ,
palpate due to edema
Temperature normal warm
Capillary refill normal
8/10/2019 Wound Assess 01.10.10
96/115
cers
Above malleolus Edema
Weeping lesions
Irregular wound edges
Shallow de th
Pain relief with elevation
enous cer anagemen
8/10/2019 Wound Assess 01.10.10
97/115
enous cer anagemen
Ambulation
Ulcer care to maintain moist wound environment
Compression to reduce pressure differential andmaintain capillary function
o s , gvar s g suppor o mo era e compress on UNNA boot non-elastic compression
2 layer wrap 20-25 mm Hg
4 layer wrap 40 mm Hg (profore)
No compression for arterial insufficiency, CHF,
r er a cers
8/10/2019 Wound Assess 01.10.10
98/115
r er a cers
OCCLUSION OFARTERIES
(arteriosclerosis
or atherosclerosis)
Known as PAD
Intermittent claudication
Characteristics of Arterial
cers
8/10/2019 Wound Assess 01.10.10
99/115
cers ,
Small, Round, Shallow Depth
Pain with leg elevation
Absent or diminished pulse
cera on or gangrene o e ower ex rem y
ABI
8/10/2019 Wound Assess 01.10.10
100/115
an ever y o
applied n e rac a n ex
Using Doppler:
Ankle Arterial BP
Brachial Arterial BP
= ABI
Signs and Symptoms of
r er a nsu c ency
8/10/2019 Wound Assess 01.10.10
101/115
r er a nsu c ency
Cramping or Aching Sensation in Calf Associated with Walking
Relieved with Rest
Femoral and Pedal Pulse Present
Dela ed Ca illar Refill >3 seconds
Skin Pallor when Leg Elevated >1 minute
Signs and Symptoms of
r er a nsu c ency
8/10/2019 Wound Assess 01.10.10
102/115
r er a nsu c ency
Pain with Elevation
Wound/Ulcers on Tips of Toes, Toes, Foot, Rarely
Above Calf
Ulceration or Gangrene
ABI
8/10/2019 Wound Assess 01.10.10
103/115
r er a cer anagemen
revascularization
Moisturize dry skin, Do not apply between
toes Avoid trauma
Wound care moist wound healing ifade uate blood flow
- europa c cer
8/10/2019 Wound Assess 01.10.10
104/115
europa c cer ,
autonomic changes, motor changes er p era vascu ar sease
Plantar
Usually granular
Minimal drainage
Callous wound edges Boundin ulses
Signs and Symptoms of
a e c europa y
8/10/2019 Wound Assess 01.10.10
105/115
a e c europa y
pale color, delayed capillary refill or may be normal
Diminished hair distribution
Warm or cold to touch
Sensory Changes loss of sensation
- Autonomic Changes absence of sweat/oil
production Ingrown or thickened toenails
Dry cracked areas, fissures
, , ,flat foot, Charcot degeneration
arco r ropa y
8/10/2019 Wound Assess 01.10.10
106/115
arco r ropa y
No Pain on Ambulation Edematous and Warm
X-ray with Abnormality
Rocker Bottom Foot
R/O Osteom elitis
Bone biopsy MRI is more accurate but ex ensive
Very Important to Listen to
a en oroug s ory
8/10/2019 Wound Assess 01.10.10
107/115
a en oroug s ory
Where is the pain?
Do you have swelling in your legs?
What factors aggravate or relieve pain?
Describe the pain: Aching? Burning? Constant? Intermittent?
Neuropathic Ulcer
Management
8/10/2019 Wound Assess 01.10.10
108/115
Management
Off-loading
Patient education
Total contact casting
Hyperbaric oxygen Growth factors
a en uca on
8/10/2019 Wound Assess 01.10.10
109/115
Avoid chemical, mechanical and thermal trauma
Wash, dry well, especially between toes
, Avoid temperature extremes
Avoid walking on hot surfaces (beach, sidewalk)
a en uca on
8/10/2019 Wound Assess 01.10.10
110/115
,
Avoid chemical agents (corn, callus remover
Avoid adhesive tape
Do not cut own calluses/corns
,
Wear stockings or socks with shoes -
a en uca on
8/10/2019 Wound Assess 01.10.10
111/115
NO bathroom surgery
Notify MD ASAP if blister or ulcer develops
,sheepskin, heel protectors
Keep tetanus current
ummary: ey o n s
8/10/2019 Wound Assess 01.10.10
112/115
y y
Aggressive treatment of infection
Dee debridement
Pressure relief
Patient education
Glucose control
Collaboration Nutritionist, MD, Podiatrist, PT
ons er a erna ve erap es
Topical avoid harmful agent
8/10/2019 Wound Assess 01.10.10
113/115
REMEMBER:
for successful management of
patients with lower extremity
What is To ical O2
Therapy?
8/10/2019 Wound Assess 01.10.10
114/115
py
providing pure oxygen directly to the wound
Oxygen is delivered directly to the surface of
e woun Topical Oxygen Therapy provides a natural,
sa e an non nvas ve a erna ve or woun
healing that can be administered in any
Topical Oxygen Wound
erapy
8/10/2019 Wound Assess 01.10.10
115/115
One-time Use, Portable
90 Minutes Per Treatment
3 Days Rest Re eat C cle Until Wound Is Healed